251 related articles for article (PubMed ID: 20819909)
1. An integrated genomic analysis of aryl hydrocarbon receptor-mediated inhibition of B-cell differentiation.
De Abrew KN; Kaminski NE; Thomas RS
Toxicol Sci; 2010 Dec; 118(2):454-69. PubMed ID: 20819909
[TBL] [Abstract][Full Text] [Related]
2. Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells.
Sulentic CE; Holsapple MP; Kaminski NE
Mol Pharmacol; 1998 Apr; 53(4):623-9. PubMed ID: 9547351
[TBL] [Abstract][Full Text] [Related]
3. Integration of genome-wide computation DRE search, AhR ChIP-chip and gene expression analyses of TCDD-elicited responses in the mouse liver.
Dere E; Lo R; Celius T; Matthews J; Zacharewski TR
BMC Genomics; 2011 Jul; 12():365. PubMed ID: 21762485
[TBL] [Abstract][Full Text] [Related]
4. Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activated B cells.
Suh J; Jeon YJ; Kim HM; Kang JS; Kaminski NE; Yang KH
Toxicol Appl Pharmacol; 2002 Jun; 181(2):116-23. PubMed ID: 12051995
[TBL] [Abstract][Full Text] [Related]
5. Involvement of Blimp-1 and AP-1 dysregulation in the 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated suppression of the IgM response by B cells.
Schneider D; Manzan MA; Yoo BS; Crawford RB; Kaminski N
Toxicol Sci; 2009 Apr; 108(2):377-88. PubMed ID: 19237549
[TBL] [Abstract][Full Text] [Related]
6. Suppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6.
Phadnis-Moghe AS; Crawford RB; Kaminski NE
Toxicol Sci; 2015 Mar; 144(1):39-50. PubMed ID: 25543051
[TBL] [Abstract][Full Text] [Related]
7. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated impairment of B cell differentiation involves dysregulation of paired box 5 (Pax5) isoform, Pax5a.
Schneider D; Manzan MA; Crawford RB; Chen W; Kaminski NE
J Pharmacol Exp Ther; 2008 Aug; 326(2):463-74. PubMed ID: 18483191
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Bach2 by the aryl hydrocarbon receptor as a mechanism for suppression of B-cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
De Abrew KN; Phadnis AS; Crawford RB; Kaminski NE; Thomas RS
Toxicol Appl Pharmacol; 2011 Apr; 252(2):150-8. PubMed ID: 21296099
[TBL] [Abstract][Full Text] [Related]
9. The AhR and NF-κB/Rel Proteins Mediate the Inhibitory Effect of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin on the 3' Immunoglobulin Heavy Chain Regulatory Region.
Salisbury RL; Sulentic CE
Toxicol Sci; 2015 Dec; 148(2):443-59. PubMed ID: 26377645
[TBL] [Abstract][Full Text] [Related]
10. Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway.
Sulentic CE; Holsapple MP; Kaminski NE
J Pharmacol Exp Ther; 2000 Nov; 295(2):705-16. PubMed ID: 11046109
[TBL] [Abstract][Full Text] [Related]
11. Differential gene regulation by the human and mouse aryl hydrocarbon receptor.
Flaveny CA; Murray IA; Perdew GH
Toxicol Sci; 2010 Apr; 114(2):217-25. PubMed ID: 20044593
[TBL] [Abstract][Full Text] [Related]
12. Developmental exposure to 2,3,7,8 tetrachlorodibenzo-p-dioxin attenuates capacity of hematopoietic stem cells to undergo lymphocyte differentiation.
Ahrenhoerster LS; Tate ER; Lakatos PA; Wang X; Laiosa MD
Toxicol Appl Pharmacol; 2014 Jun; 277(2):172-82. PubMed ID: 24709672
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of TCDD-induced AhR-mediated gene expression in human, mouse and rat primary B cells.
Kovalova N; Nault R; Crawford R; Zacharewski TR; Kaminski NE
Toxicol Appl Pharmacol; 2017 Feb; 316():95-106. PubMed ID: 27913140
[TBL] [Abstract][Full Text] [Related]
14. High-resolution genome-wide mapping of AHR and ARNT binding sites by ChIP-Seq.
Lo R; Matthews J
Toxicol Sci; 2012 Dec; 130(2):349-61. PubMed ID: 22903824
[TBL] [Abstract][Full Text] [Related]
15. Identification of aryl hydrocarbon receptor binding targets in mouse hepatic tissue treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Lo R; Celius T; Forgacs AL; Dere E; MacPherson L; Harper P; Zacharewski T; Matthews J
Toxicol Appl Pharmacol; 2011 Nov; 257(1):38-47. PubMed ID: 21889950
[TBL] [Abstract][Full Text] [Related]
16. Genome-Wide ChIPseq Analysis of AhR, COUP-TF, and HNF4 Enrichment in TCDD-Treated Mouse Liver.
Cholico GN; Nault R; Zacharewski TR
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163483
[TBL] [Abstract][Full Text] [Related]
17. All-or-none suppression of B cell terminal differentiation by environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Zhang Q; Kline DE; Bhattacharya S; Crawford RB; Conolly RB; Thomas RS; Andersen ME; Kaminski NE
Toxicol Appl Pharmacol; 2013 Apr; 268(1):17-26. PubMed ID: 23357550
[TBL] [Abstract][Full Text] [Related]
18. T lymphocytes are direct, aryl hydrocarbon receptor (AhR)-dependent targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): AhR expression in both CD4+ and CD8+ T cells is necessary for full suppression of a cytotoxic T lymphocyte response by TCDD.
Kerkvliet NI; Shepherd DM; Baecher-Steppan L
Toxicol Appl Pharmacol; 2002 Dec; 185(2):146-52. PubMed ID: 12490139
[TBL] [Abstract][Full Text] [Related]
19. Induction of the aryl hydrocarbon receptor-responsive genes and modulation of the immunoglobulin M response by 2,3,7,8-tetrachlorodibenzo-p-dioxin in primary human B cells.
Lu H; Crawford RB; Suarez-Martinez JE; Kaplan BL; Kaminski NE
Toxicol Sci; 2010 Nov; 118(1):86-97. PubMed ID: 20702590
[TBL] [Abstract][Full Text] [Related]
20. Low-dose dioxins alter gene expression related to cholesterol biosynthesis, lipogenesis, and glucose metabolism through the aryl hydrocarbon receptor-mediated pathway in mouse liver.
Sato S; Shirakawa H; Tomita S; Ohsaki Y; Haketa K; Tooi O; Santo N; Tohkin M; Furukawa Y; Gonzalez FJ; Komai M
Toxicol Appl Pharmacol; 2008 May; 229(1):10-9. PubMed ID: 18295293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
